GE Healthcare is seeking to accelerate research on the prevention, diagnosis and treatment of tendon injuries (tendinopathy).
The company has teamed up with the National Basketball Association (NBA) in the United States to launch a call for research proposals focused on tendinopathy. The two partners plan to support research into musculoskeletal injuries that affect basketball players and the general population alike.
In particular, this call for proposals seeks to address the natural history of tendinopathy in competitive athletes, the anatomic and dynamic factors that can lead to a negative impact on training or game play, and the interventions that can be effective for prevention and treatment.
GE Healthcare and the NBA will award a total of up to $1.5 million (£982,000) over a three-year period to support research projects of all sizes. The maximum amount available for an individual grant is $300,000 (£197,000).
“GE Healthcare is investing in research and development to fast-track advancement in musculoskeletal health,” commented Kelly Piacsek, vice president and general manager at GE Healthcare Global Research. “Through our research collaboration and call for proposals focused on tendinopathy, we hope to encourage scientists, researchers, doctors and innovators worldwide to bring their talents to this effort, accelerate the current understanding of tendinopathy injuries and improve how clinicians leverage state-of-the-art diagnostic tools to advance the understanding, treatment and prevention of these injuries.”
Future calls for proposals may address bone stress injuries, articular cartilage injury and other musculoskeletal issues that affect basketball players.